baber/WOPTO huggingface dataset:
Patent NZ-244340-A (NZ)
Title: Use of rapamycin in treating immunoinflammatory skin or bowel diseases
Inventor: CAUFIELD CRAIG EUGENE
IPC: A61P17/00
Filed: 1992-09-15
Abstract: Use of rapamycin (I) opt. in combination with cyclosporin A for mfr. of a medicament for treating immunoinflammatory skin or bowel diseases in mammals is new. Pref. the medicament is adapted for oral, parenteral, intranasal, intrabronchial, topical, transdermal or rectal admin. The medicament is in unit dosage form, each unit contg. 0.001-100 pref. 0.1-50 esp. 0.3-25 mg/kg (I).
Patent NZ-247277-A (NZ)
Title: Imidazolyl-substituted arylsulphonylamino derivatives of piperidine; methods of preparation and pharmaceutical compositions thereof
Inventor: LASSALLE GILBERT
IPC: C07D401/06
Filed: 1993-03-29
Abstract: Compounds of the invention corresponding to the formula (I) <IMAGE>  in which R represents a group <IMAGE> where R2 is a hydrogen atom, a (C1-C4)alkoxycarbonyl group, a carboxyl group, a sodium carboxylate group, a -CH2OR4 group, R4 being a hydrogen atom, a (C1-C4)alkyl group or a (C1-C4)acyl group, an amide group of formula -CONR5R6 or a -CN4R5 group, R5 being a hydrogen atom or a (C1-C4)alkyl group and R6 being a hydrogen atom, a (C1-C4)alkyl group, a hydroxyl group, a (C1-C4)alkoxy group or a (C1-C3)alkoxyphenyl group and R3 is a (C1-C4)alkyl group, R1 represents either a hydrogen atom or a (C1-C4)alkyl group, X represents either a sulphur atom or an oxygen atom or a methylene group, n = 1 or 2 and Ar represents either a 1-naphthyl group substituted by a di(C1-C4)alkylamino group, or a 6,7-di(C1-C4)alkoxy-1-naphthyl group, or a 8-quinolyl group substituted in the 3 position by a (C1-C4)alkyl group, or a 1,2,3,4-tetrahydro-8-quinolyl group substituted in the 3 position by a (C1-C4)alkyl group, or a 1H-indazol-7-yl group,  and their addition salts with pharmaceutically acceptable acids. Application in therapeutics.
Patent NZ-254658-A (NZ)
Title: Absorbent article - extensible side wrapping elements affixed at points on but otherwise unattached to, the garment facing side of the article
Inventor: LAVASH BRUCE WILLIAM
IPC: A61F13/42
Filed: 1993-07-22
Abstract: The present invention relates to absorbent articles such as sanitary napkins worn by women. More particularly, the present invention relates to absorbent articles, such as thin sanitary napkins, that are stretchable, especially in the longitudinal direction.
Patent NZ-267702-A (NZ)
Title: Billiards table; details of playing bed and of table edges
Inventor: FROST BARRY JOHN
IPC: A63D15/00
Filed: 1994-07-01
Abstract: PCT No. PCT/GB94/01432 Sec. 371 Date Jun. 17, 1996 Sec. 102(e) Date Jun. 17, 1996 PCT Filed Jul. 1, 1994 PCT Pub. No. WO95/01211 PCT Pub. Date Jan. 12, 1995A billiards table comprises a playing bed (12) of sandwich construction having a playing surface which mimics the bounce of slate for a billiards ball, an edge member (16) for the surface formed of moulded plastics and having a cushioned surface, and legs (15) fixed to the underside of the table. The edge member (16) incorporates channel formations (21) to receive the balls, which communicate with the pockets through the edge. The playing surface may be cloth covered (as is conventional) or may have a simulated cloth surface moulded on a plastic top layer.
Patent NZ-268138-A (NZ)
Title: Preparation of a pharmaceutically active polypeptide and a substance enhancing its absorption in the lower respiratory tract in the form of a dry powder suitable for inhalation
Inventor: BAECKSTROEM KJELL GOERAN ERIK
IPC: A61K38/095
Filed: 1994-06-23
Abstract: A pharmaceutical composition including a mixture of active compounds (A) a pharmaceutically active polypeptide, and (B) an enhancer compound which enhances the systemic absorption of the polypeptide in the lower respiratory tract of a patient, the mixture being in the form of a dry powder for inhalation in which at least 50% of the total mass of the active compounds consists of primary particles having a diameter less than or equal to about 10 microns, the primary particles optionally being formed into agglomerates.
Patent NZ-284802-A (NZ)
Title: Use of 4-amino-2,2,6,6-tetramethyl piperidine derivatives in a process for producing inherently light- and heat-stabilised polyamides
Inventor: WEINERTH KLAUS
IPC: D03D15/283
Filed: 1995-04-12
Abstract: A process for preparing inherently light- and heat-stabilized polyamides comprises polymerizing in the presence of at least one triacetonediamine compound of the formulawhere R is hydrogen or hydrocarbyl having from 1 to 20 carbon atoms, preferably alkyl having from 1 to 18 carbon atoms, or benzyl.
Patent NZ-329979-A (NZ)
Title: Use of NK3 receptor antagonists
Inventor: FARINA CARLO
IPC: A61K31/45
Filed: 1995-05-23
Abstract: Use of an NK3 receptor antagonist in the manufacture of a medicament for treating convulsive disorders, epilepsy, renal disorders, urinary incontinence, ocular inflammation, inflammatory pain, eating disorders, allergic rhinitis, neurodegenerative disorders, psoriasis, Huntingtons disease and depression.
Patent NZ-331216-A (NZ)
Title: Telecommunications networks for handling non-time -critical calls (NTCC)
Inventor: HOY MICHAEL DAVEY
IPC: H04M3/00
Filed: 1997-02-27
Abstract: The specification describes a telecommunications network of the kind which handles non-time-critical calls (NTCC) in addition to normal telephony, a congestion indication is transmitted to NTCC transmitting platforms if volume and/or rate limit for a particular communications route or switch is exceeded. Transmitting platforms (9, 10, 11) establish a transmission rate based on a gaping rate (GR). On receipt of a congestion signal the platforms calculate an Inter call delay based on a random number multiplied by a weighting factor determined from the current value of GR. This provides a period during which calls are not attempted after which GR is adjusted using a common ratio to provide a higher value of GR thus transmission rate (or the rate at which calls are offered) to the congestion route is less onerous. Consecutive call failures result in a rapid increase in the value of GR leading to longer ICDs (to allow the congested route/switch to recover) and a lower traffic loading on recovery. Further, multiple transmitting platforms resume sending at different times due to randomisation of ICDs across platforms.
Patent NZ-332828-A (NZ)
Title: Manufacturing glued timber blocks using press with pressure plates and lateral stops
Inventor: HOLMBERG HANS
IPC: B27M3/00
Filed: 1997-06-17
Abstract: Process for the manufacturing of a glued block of triangular cross-section, elongated staves of wood where the staves for forming a block are laid beside each other with alternate staves with their base sides downwards and apex edges upwards and alternate ones with their base sides upwards and apex edges downwards, and glue applied between adjacent surfaces between the staves, characterized by locking the staves side by side between sides supports; exerting the main pressure force to glue the staves firmly together is transverse to the base sides of the staves by movement of a common pressure plate.
Patent NZ-335443-A (NZ)
Title: Process for the preparation of vinyl acetate
Inventor: TUSTIN GERALD CHARLES
IPC: C07C67/46
Filed: 1997-08-13
Abstract: process for preparing vinyl acetate comprising the steps of: 1)	contacting at a temperature of 85 to 200oC and at a pressure of 0.05 to 20 bars (5 to 2000 kPa) absolute a mixture of ketene and acetaldehyde and, optionally, a nonreactive diluent gas with an acid catalyst in a contact zone and 2)	recovering vinyl acetate from the contact zone.
Patent NZ-501880-A (NZ)
Title: Process for preparing enantiomerically pure N-protected (1R,4S)-2-azabicyclo [2.2.1] hept-5-en-3-one lactams
Inventor: DAWSON MICHAEL JOHN
IPC: A61K31/16
Filed: 1998-08-20
Abstract: To prepare enantiomerically pure N-protected (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one of the formula IV, P being an activating and protecting group, a racemic mixture of N-protected (±) 2-azabicyclo[2.2.1]hept-5-en-3-one of formula V is treated with an acylase enzyme and the unreacted enantiomer of formula IV is isolated from the reaction mixture.
Patent NZ-502111-A (NZ)
Title: Inhibition of sulphate-reducing-bacteria-mediated degradation using bacteria which secrete antimicrobials
Inventor: WOOD THOMAS K
IPC: A01N63/27
Filed: 1999-05-03
Abstract: The use of bacteria which, either naturally or through the use of recombinant technology, secrete chemical compositions which inhibit the growth of sulfate-reducing bacteria on metals, concrete, mortar, and other surfaces subject to corrosion.
Patent NZ-503592-A (NZ)
Title: Encoding multiword information by wordwise interleaving
Inventor: YAMAMOTO KOUHEI
IPC: G11B20/18
Filed: 1999-07-19
Abstract: Multiword information is based on multibit symbols disposed in relative contiguity with respect to a medium, and is encoded with a wordwise interleaving and wordwise error protection code for providing error locative clues across multiword groups. In particular, the clues originate in high protectivity clue words  (BIS) that are interleaved among clue columns, and also in synchronizing columns constituted from synchronising bit groups. The synchronising columns are located where the clue words are relatively scarcer disposed. The clues are directed to low protectivity target words (LDS) that are interleaved in a substantially uniform manner among target columns, which form uniform sized column groups between periodic arrangements of clue columns and synchronising columns.
Patent NZ-504143-A (NZ)
Title: Collapsible shipping and display rack comprising vertically pivotable shelves
Inventor: MAST RICHARD
IPC: A47F5/10
Filed: 2000-04-20
Abstract: Described is a collapsible shipping and display rack.  The rack (10) has: At least four vertical corner posts (14), Two opposing center columns (12) between two of the vertical posts, One or more rectangularly-shaped shelves (18).  The shelves have corners which are pivotally mounted to one of the posts and their rear left and right corners are pivotally mounted to one of the columns.  The rack is movable, and in the collapsed mode the shelves are oriented vertically.  A strut (60) is adjustably mounted to the columns and is itself collapsible.
Patent NZ-512500-A (NZ)
Title: Process for preparing a 2-halo-3-nitro-4-aminopyridine compound
Inventor: SHERBINE JAMES P
IPC: A61P3/06
Filed: 1999-12-14
Abstract: A process for preparing a 2-halo-3-nitro-4-aminopyridine compound of formula (I) by reacting a compound of formula (IV) with an amine of formula H2N-X-(Y)a-Z. All variables are defined as follows: X is alkylene, cycloalkylene or cycloalkenylene; X2 is Cl or F; Y is NR4, O or S; a is 0 or 1; Z is represented by formula (II) or formula (III), where Z1 is N, CR5, (CH)m-CR5 or (CH2)m-N (m being 1 or 2) and Z2 is N, NR6, O or S (n being 0 or 1) and Ra and Rb are independently H, OH, alkyl, hydroxyalkyl, alkylmercaptyl, thioalkyl, alkoxy, alkoxyalkyl, amino, alkylamino, carboxyl, acyl, halogen, carbamoyl, alkylcarbamoyl, aryl or heterocyclyl; R4, R5 and R6 are independently H, alkyl, aryl or heterocycyl; X1 is F
Patent NZ-514270-A (NZ)
Title: Pharmaceutical compounds
Inventor: DEL SOLDATO PIERO
IPC: A61P25/28
Filed: 2000-04-11
Abstract: A compound or its salts thereof has the formula (I) A- (B)b0-C-N(O)2 wherein: b0 is 0 or 1; A is R-T1-; R is radical of a drug such that A has the formula R-T1-Z or R-T1-OZ; Z is H or alkyl; T1 is (CO)t or (X)t'; X is O, S, NR1C; R1C is H, alkyl, or a free valence; t and t' are independently 0 or 1 provided that that t is 1 when t' is 0 and t is 0 when t' is 1; B is -TB-X2-TBI-; TB is (CO) when t is 0 or TB is X when t' is 0; TBI is (CO)tx or (X)txx; tx and txx are independently 0 or 1 provided that tx is 1 when txx is 0, and tx is 0 when txx is 1; X2 is a bivalent bridging bond as defined in the specification; C is -TC-Y-; Tc is (CO) when tx is 0 or is X when txx is 0; Y is -[C(RTIX)(RTIX')]nIX-Y3-C(RTIIX)(RTIIX')]nIIx or Y0; RTIX, RTIX', nIX, Y3, RTIIX, RTIIX', nIIx and Y0 are as defined in the specification; provided that in formula (I) when b0 is 0 and C is -Tc-Y0- then the drug radical R is not an ACE-inhibitor or an anti- inflammatory drug The drug is defined in the specification and can be an anti- inflammatory drug such as aceclofenac, analgesic drug such as acetaminophen, bronchodilator and drug active on the cholinergic system such as acefylline, expectorant/mucolytic drug such as ambroxol, antiasthmatic/antiallergic antihistaminic drug such as acrivastine, ACE-inhibitor such as alacepril, beta-blocker such as acebutolol, vasoactive drug such as acetorphan, antidiabetic drug such as acarbose, antitumoral drug such as ancitabine, antiulcer drug such as arbaprostil, antibiotic such as amdinocillin, antiviral drug such as acyclovir, bone resorption inhibitor such as alendronic acid, antidementia drug such as amiridine.
Patent NZ-516740-A (NZ)
Title: Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives
Inventor: THOMAS ANDREW PETER
IPC: A61P37/02
Filed: 2000-08-15
Abstract: Imidazo[1,2-A]pyridine and pyrazolo[2,3-A]pyridine derivatives of formula (I), useful for their anti-cell-proliferation (such as anti-cancer) activity, due to their inhibition of the effects of cell cycle kinases showing selectivity for CDK2, CDK4 and CDK6.
Patent NZ-522660-A (NZ)
Title: Novel heterocyclic analogs of diphenylethylene compounds
Inventor: NEOGI PARTHA
IPC: A61P1/04
Filed: 2001-06-05
Abstract: Diphenylethylene compounds of formula (I) and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties, which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes are disclosed, wherein Z is represented by formula (II) and other substituents shown in these formulae are as defined in the specification. In contrast to previously reported thiazolidinedione compounds, known to lower leptin levels, the present compounds increase leptin levels and have no known liver toxicity. These compounds are suitable for use in a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.
Patent NZ-526672-A (NZ)
Title: Process for forming crystalline human insulin-like growth factor-1
Inventor: SCHAFFER MICHELLE
IPC: C07K14/65
Filed: 2002-02-01
Abstract: Crystalline IGF-1 is provided along with a method for production thereof. Crystallising IGF-1 comprises the steps of mixing an aqueous solution comprising IGF-1 with a reservoir solution comprising a precipitant to form a mixture; and crystallising the mixture, optionally also recrystallising and isolating the crystalline IGF-1. In addition, a method for identifying IGF-1 indirect agonists is provided using a detergent as a standard for the level of inhibition of binding of IGFBP-1 or IGFBP-3 to IGF-1 and/or using the coordinates of the binding pockets of IGF-1 to which a candidate indirect agonist binds for structure-based drug design.
Patent NZ-528129-A (NZ)
Title: Inductive signal transfer transformer for electric fence signalling
Inventor: JOHNSTON RICHARD LLOYD
IPC: H01F38/14
Filed: 2003-09-09
Abstract: An inductive high voltage isolation signal transfer device for use in signalling along electric fence systems and isolating the high voltage fence pulses from the output, includes a pair of axially aligned insulation shrouded coils, one serving as an input with terminals 2 and the other as an output with terminals 10, and coupling a signal by magnetic induction between the input and output terminals. The respective shrouds are configured to fit together to set the separation distance between the coils. This ensures that the coupling between the coils does not have to be calibrated after assembly and that the terminals are separated and isolated in accordance with specified isolation standards.
Patent NZ-534553-A (NZ)
Title: Antibodies specific for early conception factor and methods for detecting conception in animals
Inventor: JORDAN NANCY TOMMYE
IPC: G01N33/577
Filed: 1999-02-02
Abstract: An isolated antibody which specifically binds purified early conception factor wherein ECF has a molecular weight of from about 190,000 daltons to about 205,000 daltons is described. A method for detecting conception in an animal comprises detecting the presence of early conception factor in a sample of body fluid from the animal.
Patent NZ-535898-A (NZ)
Title: Detection of drum position in laundry appliance
Inventor: JACKSON RUSSELL JOSEPH
Filed: 2003-04-11
Abstract: A laundry machine includes a cabinet and a laundry holding drum rotatably supported within the cabinet for rotation. The drum includes a drum end (726) including an annular series of regularly spaced deformities (950). A motor drives rotation of the drum. A light source (910) is positioned in the cabinet to illuminate a location through which the annular series of deformities are passed by rotation of the drum. A light detector (910) receives reflected light from the light source off the drum end. A controller is operatively connected with the motor and the light detector, the controller being configured to operate the motor to drive the drum, and to receive signals from the light detector and process the signals to determine rotational characteristics of the drum.
Patent NZ-536766-A (NZ)
Title: Anti-p53 antibodies
Inventor: WARD ROBYN LYNNE
IPC: C12Q1/68
Filed: 2000-03-15
Abstract: An isolated and purified nucleic acid sequence comprises a sequence encoding complimentarity determining region (CDR) of a human antibody. The antibody has a specific sequence and has a binding affinity to a p53 protein. An immune response is induced against diseases characterized by expression of p53 as a result. (62) Divided Out of 513976
Patent NZ-537734-A (NZ)
Title: Method of allocating advertising advertising space & system therefore
Inventor: WINTON ANDREW
IPC: G09F19/22
Filed: 2002-12-06
Abstract: A system for the application of an image to an upper surface of a built structure, the image arranged for visibility from over-flying craft. An upper surface of a built structure incorporating indicia thereon on therein; the indicia constructed so as to be discernable by observers in craft passing over the built structure when the craft is within a predetermined legibility distance of the built structure. Patent of Addition filed as 546847
Patent NZ-537804-A (NZ)
Title: Sanitary manifold system and method for hygienically dispensing fluids
Inventor: CARHUFF PETER
IPC: B67D1/07
Filed: 2003-06-13
Abstract: Methods and apparatus for the dispensing of a microbiologically sensitive fluid from a container assembly to a dispensing unit, in particular low acid food fluid, in a hygienic manner so as to avoid micro-organism growth in the line dispensing the fluid as well as in any mechanical components of the dispensing unit are disclosed. The container assembly includes a hose (21) and a package and connects to a sanitary manifold system by a terminal connecting portion (21, 22). The system includes a housing, a discharge line (60) for delivering the fluid to the dispensing unit, an interface port for establishing a connection between the terminal connecting portion to the discharge line, and a cleaning fluid line assembly (33) for supplying a cleaning or rinsing fluid (F) to the discharge line. The cleaning fluid line assembly (33) has a projection member arranged to deliver the cleaning fluid within the terminal connecting portion, and an external valve is used to maintain the upstream portion of the hose and package sterile or quasi-sterile and isolated from the terminal connecting portion to allow cleaning of the hose from the interface port up to the closing of the valve. The projection member is reciprocally mounted in the housing to move from a retracted position to an inserted cleaning position, where the projection member protrudes past the interface port and into the terminal connecting portion to deliver the cleaning or rinsing fluid.
Patent NZ-540109-A (NZ)
Title: Stable ethylene inhibiting compounds and methods for their preparation
Inventor: JACOBSON RICHARD MARTIN
IPC: C07C211/17
Filed: 2003-07-24
Abstract: Disclosed herein is a method to inhibit the ethylene response in plants with cyclopropene compounds by first generating stable cyclopropane precursor compounds and then converting these compounds to the gaseous cyclopropene antagonist compound by use of a reducing or nucleophilic agent, and contacting the plants with the cyclopropene compounds. (62) Divided Out of 527161
Patent NZ-542718-A (NZ)
Title: Antisense oligonucleotides (ODN) against Smad7 and uses in the medical field
Inventor: MONTELEONE GIOVANNI
IPC: A61K38/00
Filed: 2004-03-08
Abstract: Antisense oligonucleotides phosphorothioate against Smad7 up to 21 nucleotides in length that are suitably modified for use in the medical field, in particularly for use in treating chronic inflammatory diseases such as Crohn's disease and ulcerative colitis
Patent NZ-542861-A (NZ)
Title: Electronic patient monitor and white noise source
Inventor: COOPER CRAIG L
IPC: G08B21/04
Filed: 2004-03-25
Abstract: An electronic patient monitor for use in reducing the risk of decubitus ulcers. The monitor utilizes a separate sensor which senses the position of the patient in the bed or chair for purposes of determining when the patient moves. Additionally, the monitor broadcasts masking noise through its own, or through a remote, speaker, thereby enabling the patient to rest more comfortably in a noisy institutional environment. If the patient does not move on his or her own accord within a predetermined turn interval, the masking sound broadcast will be terminated which will gently encourage the patient to move. An alarm may additionally be sounded to notify the caregiver that the patient needs to be manually turned to reduce the risk of decubitus ulcers.
Patent NZ-543539-A (NZ)
Title: Modification to plant responses to salt
Inventor: SPANGENBERG GERMAN
IPC: C07K14/415
Filed: 2002-10-04
Abstract: Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding an early salt-responding glucose 6 phosphate 1 dehydrogenase (WESR5) from a Lolium species, or a functionally active fragment or variant thereof.
Patent NZ-549853-A (NZ)
Title: Gastric retention system
Inventor: DHARMADHIKARI NITIN BHALACHAND
IPC: A61K9/00
Filed: 2005-03-24
Abstract: A gastric retention system in the form of a coated tablet or a coated capsule is disclosed, which comprises: (a) a core in the form of a tablet comprising an agent capable of generating internal pressure, selected from at least one of the group consisting of a gas generating agent, a superdisintegrant, a swellable polymer or a mixture of these, (b) an expandable coating formed by applying a coating composition comprising a film-forming polymer and one or more expandable components selected from a gas generating agent, a superdisintegrant, a swellable polymer or a mixture of these on the tablet core to form a film capable of expanding and maintaining its physical integrity in the gastric milleu. Also disclosed is a process for forming an expandable coating on a tablet or capsule core comprising applying to the tablet or capsule core, in a dry powder form or suspended in a non-solvent vehicle, a coating composition comprising a film forming polymer and components capable of expanding.
Patent NZ-550373-A (NZ)
Title: Wireless communication with household appliances
Inventor: HAYES BOBBY
IPC: H04M1/00
Filed: 2005-04-28
Abstract: A communication arrangement for a household appliance device is provided. The arrangement includes a first communication part including a transmitter for transmitting a wireless signal; and a second communication part, remotely located from the first communication part, including a receiver for receiving the wireless signal. One of the first and second communication parts is associated with the appliance device, and the second communication part includes means to over sample the signal in order to nullify the effects of noise transmitted in the signal.